Healthcare Global Enterprises · NSE: HCG · BSE: 539787
Q2 FY23 results · Jul–Sep 2022
Healthcare Global Enterprises reported revenue from operations of ₹420.00 crore (up 19.3% from Q2 FY22) and net profit of ₹5.29 crore (down 94.7% from Q2 FY22) for Q2 FY23 (Jul–Sep 2022), on a consolidated basis.
| Item | Q2 FY23 | Q2 FY22 | YoY | Q1 FY23 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 420.00 | 351.96 | +19.3% | 408.05 | +2.9% |
| Other income | 1.97 | 3.30 | −40.3% | 2.91 | −32.3% |
| Total income | 421.97 | 355.26 | +18.8% | 410.96 | +2.7% |
| Profit before tax | 10.02 | 143.91 | −93.0% | 10.42 | −3.8% |
| Net profit for the period | 5.29 | 98.99 | −94.7% | 2.48 | +113.3% |
| Attributable to shareholders of the company | 7.38 | 103.09 | −92.8% | 6.05 | +22.0% |
| EPS, basic (₹) | 0.53 | 8.22 | not comparable | 0.44 | +20.5% |
| Net margin (%) | 1.3 | 28.1 | 0.6 |
| Item | Q2 FY23 | Q2 FY22 | YoY | Q1 FY23 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 253.07 | 215.66 | +17.3% | 243.17 | +4.1% |
| Other income | 1.27 | 1.54 | −17.5% | 1.87 | −32.1% |
| Total income | 254.34 | 217.20 | +17.1% | 245.04 | +3.8% |
| Profit before tax | 13.92 | 132.70 | −89.5% | 16.41 | −15.2% |
| Net profit for the period | 11.00 | 93.90 | −88.3% | 10.85 | +1.4% |
| EPS, basic (₹) | 0.79 | 7.49 | not comparable | 0.78 | +1.3% |
| Net margin (%) | 4.3 | 43.5 | 4.5 |
Consolidated
- Filed with BSE
- 11 Nov 2022, 10:29 IST
- Board meeting
- 10 Nov 2022
- Period
- 01 Jul 2022 to 30 Sep 2022
- Review status
- Unaudited
- Source
- XBRL filing on BSE
Standalone
- Filed with BSE
- 11 Nov 2022, 10:29 IST
- Board meeting
- 10 Nov 2022
- Period
- 01 Jul 2022 to 30 Sep 2022
- Review status
- Unaudited
- Source
- XBRL filing on BSE